Crossref
Efficacy, adverse drug reactions, and symptom relief from different doses of tofacitinib combined with methotrexate for rheumatoid arthritis
American Journal of Translational Research · 2026 · 18 (10) · 9138-9147
DOI: 10.62347/ifnx7855 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Li Zhang und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, L., & Shen, H. (2026). Efficacy, adverse drug reactions, and symptom relief from different doses of tofacitinib combined with methotrexate for rheumatoid arthritis. American Journal of Translational Research, 18(10), 9138-9147. https://doi.org/10.62347/ifnx7855
Vancouver
Zhang L, Shen H. Efficacy, adverse drug reactions, and symptom relief from different doses of tofacitinib combined with methotrexate for rheumatoid arthritis. American Journal of Translational Research. 2026;18(10):9138-9147. doi:10.62347/ifnx7855
BibTeX
@article{Zhang2026,
author = {Zhang, Li and Shen, Haili},
title = {Efficacy, adverse drug reactions, and symptom relief from different doses of tofacitinib combined with methotrexate for rheumatoid arthritis},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {10},
pages = {9138--9147},
doi = {10.62347/ifnx7855}
}
EUVIMED